AU2495801A
(en)
*
|
1999-12-22 |
2001-07-09 |
Innovation And Development Corporation |
Method and apparatus for targeting localised electroporation
|
DE10031179A1
(de)
*
|
2000-06-27 |
2002-01-31 |
Amaxa Gmbh |
Verfahren zur Einbringung von Nukleinsäuren und anderen biologisch aktiven Molekülen in den Kern höherer eukaryontischer Zellen mit Hilfe elektrischen Stroms
|
US7101703B2
(en)
*
|
2001-03-09 |
2006-09-05 |
Cornell Research Foundation, Inc. |
Electrofusion microelectrode
|
DE10119901A1
(de)
*
|
2001-04-23 |
2002-10-24 |
Amaxa Gmbh |
Schaltungsanordnung zur Einbringung von Nukleinsäuren und anderen biologisch aktiven Molekülen in den Kern höherer eukaryontischer Zellen mit Hilfe elektrischen Stroms
|
US6994706B2
(en)
|
2001-08-13 |
2006-02-07 |
Minnesota Medical Physics, Llc |
Apparatus and method for treatment of benign prostatic hyperplasia
|
US6713292B2
(en)
*
|
2001-12-06 |
2004-03-30 |
Bio-Rad Laboratories, Inc. |
Electroporation cuvette insert for facilitating membrane-based fusion
|
US20030129716A1
(en)
*
|
2001-12-06 |
2003-07-10 |
Bio-Rad Laboratories, Inc. |
Automatic electroporation optimization system
|
US8209006B2
(en)
*
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
US7245963B2
(en)
*
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
US6699712B2
(en)
*
|
2002-03-20 |
2004-03-02 |
Bio-Rad Laboratories, Inc. |
Electroporation chamber
|
US9982251B2
(en)
*
|
2003-03-14 |
2018-05-29 |
Cellectis S.A. |
Large volume ex vivo electroporation method
|
US6969604B1
(en)
|
2003-06-20 |
2005-11-29 |
Yakovenko Sergey A |
Electroporation chamber
|
WO2006080934A2
(en)
*
|
2004-04-19 |
2006-08-03 |
Invitrogen Corporation |
Electroporation apparatus and methods
|
US20050277183A1
(en)
*
|
2004-05-18 |
2005-12-15 |
Ronald Lee |
Electroporation cuvette
|
EP1607484B1
(de)
*
|
2004-06-14 |
2014-04-02 |
Lonza Cologne GmbH |
Verfahren und Schaltungsanordnung zur Behandlung von biologischem Material
|
US7915044B2
(en)
*
|
2005-12-22 |
2011-03-29 |
Cornell Research Foundation, Inc. |
Electrofusion microelectrode and methods of using it to manipulate cells and/or cellular components
|
KR101248799B1
(ko)
|
2006-04-28 |
2013-04-02 |
젤티크 애스세틱스, 인코포레이티드. |
피하 지질 과다 세포의 개선된 냉각을 위한 치료 장치와 함께 사용하기 위한 동결 방지제
|
US8192474B2
(en)
|
2006-09-26 |
2012-06-05 |
Zeltiq Aesthetics, Inc. |
Tissue treatment methods
|
US9132031B2
(en)
|
2006-09-26 |
2015-09-15 |
Zeltiq Aesthetics, Inc. |
Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
|
US20080077201A1
(en)
|
2006-09-26 |
2008-03-27 |
Juniper Medical, Inc. |
Cooling devices with flexible sensors
|
US7687267B2
(en)
*
|
2006-09-30 |
2010-03-30 |
Rational Biotechnology Inc. |
High-throughput cell transfection device and methods of using thereof
|
PT2066399T
(pt)
|
2006-10-17 |
2019-01-11 |
Inovio Pharmaceuticals Inc |
Dispositivos de eletroporação e métodos de usar os mesmos para eletroporação de células em mamíferos
|
ES2534579T3
(es)
*
|
2007-02-23 |
2015-04-24 |
Lonza Cologne Gmbh |
Dispositivo y procedimiento para estabilizar el flujo a través de una cámara
|
US20080287839A1
(en)
|
2007-05-18 |
2008-11-20 |
Juniper Medical, Inc. |
Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
|
US8523927B2
(en)
|
2007-07-13 |
2013-09-03 |
Zeltiq Aesthetics, Inc. |
System for treating lipid-rich regions
|
EP3488833A1
(de)
|
2007-08-21 |
2019-05-29 |
Zeltiq Aesthetics, Inc. |
Überwachung der kühlung von subkutanen lipidreichen zellen, z.b. kühlung von fettgewebe
|
US8043838B2
(en)
*
|
2008-02-20 |
2011-10-25 |
Bio-Rad Laboratories, Inc. |
Electroporation cuvette with spatially variable electric field
|
WO2009123564A1
(en)
*
|
2008-04-03 |
2009-10-08 |
Nanyang Polytechnic |
Apparatus for electroporation with cooling system
|
US10117707B2
(en)
|
2008-04-29 |
2018-11-06 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
US10238447B2
(en)
|
2008-04-29 |
2019-03-26 |
Virginia Tech Intellectual Properties, Inc. |
System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
|
CA2722296A1
(en)
|
2008-04-29 |
2009-11-05 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation to create tissue scaffolds
|
US11254926B2
(en)
|
2008-04-29 |
2022-02-22 |
Virginia Tech Intellectual Properties, Inc. |
Devices and methods for high frequency electroporation
|
US9867652B2
(en)
|
2008-04-29 |
2018-01-16 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
|
US9283051B2
(en)
|
2008-04-29 |
2016-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating a treatment volume for administering electrical-energy based therapies
|
US10245098B2
(en)
|
2008-04-29 |
2019-04-02 |
Virginia Tech Intellectual Properties, Inc. |
Acute blood-brain barrier disruption using electrical energy based therapy
|
US11272979B2
(en)
|
2008-04-29 |
2022-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
US9198733B2
(en)
|
2008-04-29 |
2015-12-01 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for electroporation-based therapies
|
US10702326B2
(en)
|
2011-07-15 |
2020-07-07 |
Virginia Tech Intellectual Properties, Inc. |
Device and method for electroporation based treatment of stenosis of a tubular body part
|
US10272178B2
(en)
|
2008-04-29 |
2019-04-30 |
Virginia Tech Intellectual Properties Inc. |
Methods for blood-brain barrier disruption using electrical energy
|
US8992517B2
(en)
|
2008-04-29 |
2015-03-31 |
Virginia Tech Intellectual Properties Inc. |
Irreversible electroporation to treat aberrant cell masses
|
US8603073B2
(en)
|
2008-12-17 |
2013-12-10 |
Zeltiq Aesthetics, Inc. |
Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
|
NO2208780T3
(de)
|
2009-01-20 |
2018-03-31 |
|
|
EP2208778A1
(de)
|
2009-01-20 |
2010-07-21 |
Lonza Cologne AG |
Verfahren und Vorrichtung zur elektrischen Behandlung von Reaktionsräumen
|
US8632534B2
(en)
*
|
2009-04-03 |
2014-01-21 |
Angiodynamics, Inc. |
Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
|
US11638603B2
(en)
|
2009-04-09 |
2023-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Selective modulation of intracellular effects of cells using pulsed electric fields
|
US11382681B2
(en)
|
2009-04-09 |
2022-07-12 |
Virginia Tech Intellectual Properties, Inc. |
Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
|
CA2975717C
(en)
|
2009-04-30 |
2020-04-28 |
Zeltiq Aesthetics, Inc. |
Device, system and method of removing heat from subcutaneous lipid-rich cells
|
US8903488B2
(en)
|
2009-05-28 |
2014-12-02 |
Angiodynamics, Inc. |
System and method for synchronizing energy delivery to the cardiac rhythm
|
US9895189B2
(en)
|
2009-06-19 |
2018-02-20 |
Angiodynamics, Inc. |
Methods of sterilization and treating infection using irreversible electroporation
|
CN102656260A
(zh)
*
|
2009-10-19 |
2012-09-05 |
瑞生生物技术有限公司 |
用于诱导自调节细胞电穿孔的方法、装置和设备
|
CN102791227A
(zh)
|
2010-01-25 |
2012-11-21 |
斯尔替克美学股份有限公司 |
用于通过相变冷却剂从皮下富脂细胞无创去除热量的家用施用器以及相关的装置、系统和方法
|
EP2399984B1
(de)
|
2010-06-22 |
2013-03-20 |
Lonza Cologne GmbH |
Verfahren und Elektrodenanordnung zur Behandlung von adhärenten Zellen
|
US8676338B2
(en)
|
2010-07-20 |
2014-03-18 |
Zeltiq Aesthetics, Inc. |
Combined modality treatment systems, methods and apparatus for body contouring applications
|
WO2012041867A2
(en)
|
2010-09-27 |
2012-04-05 |
China Agricultural University |
Combined antigen and dna vaccine for preventing and treating autoimmune diseases
|
EP2627274B1
(de)
|
2010-10-13 |
2022-12-14 |
AngioDynamics, Inc. |
System zur elektrischen ableitung des gewebes eines patienten
|
WO2012088149A2
(en)
|
2010-12-20 |
2012-06-28 |
Virginia Tech Intellectual Properties, Inc. |
High-frequency electroporation for cancer therapy
|
US9078665B2
(en)
|
2011-09-28 |
2015-07-14 |
Angiodynamics, Inc. |
Multiple treatment zone ablation probe
|
CN103239734B
(zh)
|
2012-02-10 |
2016-02-24 |
北京艾棣维欣生物技术有限公司 |
用于预防和/或治疗呼吸道合胞病毒感染的疫苗
|
WO2014093897A1
(en)
|
2012-12-13 |
2014-06-19 |
The Trustees Of The University Of Pennsylvania |
Wt1 vaccine
|
US9888956B2
(en)
|
2013-01-22 |
2018-02-13 |
Angiodynamics, Inc. |
Integrated pump and generator device and method of use
|
US9545523B2
(en)
|
2013-03-14 |
2017-01-17 |
Zeltiq Aesthetics, Inc. |
Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
|
US9844460B2
(en)
|
2013-03-14 |
2017-12-19 |
Zeltiq Aesthetics, Inc. |
Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
|
US10364451B2
(en)
|
2013-05-30 |
2019-07-30 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
US9592303B2
(en)
|
2013-05-30 |
2017-03-14 |
Duke University |
Enzyme-catalyzed synthesis of site-specific and stoichiometric biomolecule-polymer conjugates
|
US10392611B2
(en)
|
2013-05-30 |
2019-08-27 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
CN105744953B
(zh)
|
2013-10-07 |
2020-01-17 |
宾夕法尼亚大学理事会 |
具有作为佐剂的白介素-33的疫苗
|
WO2015070027A1
(en)
|
2013-11-07 |
2015-05-14 |
University Of Southern California |
Use of ikk epsilon inhibitors to activate nfat and t cell response
|
WO2015073291A1
(en)
|
2013-11-14 |
2015-05-21 |
The Trustees Of The University Of Pennsylvania |
Hiv-1 env dna vaccine plus protein boost
|
KR20230122181A
(ko)
|
2013-11-29 |
2023-08-22 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
중동 호흡기 증후군 코로나바이러스(MERS-CoV) 백신
|
KR102395498B1
(ko)
|
2014-01-06 |
2022-05-09 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Pd1 및 pdl1 항체 및 백신 조합 및 면역요법을 위한 이들의 사용
|
EP3099261A2
(de)
|
2014-01-31 |
2016-12-07 |
Zeltiq Aesthetics, Inc. |
Behandlungssysteme zur behandlung von cellulitis durch kühlung
|
US10675176B1
(en)
|
2014-03-19 |
2020-06-09 |
Zeltiq Aesthetics, Inc. |
Treatment systems, devices, and methods for cooling targeted tissue
|
USD777338S1
(en)
|
2014-03-20 |
2017-01-24 |
Zeltiq Aesthetics, Inc. |
Cryotherapy applicator for cooling tissue
|
EP2940120B1
(de)
|
2014-05-02 |
2018-08-01 |
Lonza Cologne GmbH |
Vorrichtung und Verfahren für großvolumige Transfektion
|
CN106715682A
(zh)
|
2014-05-12 |
2017-05-24 |
弗吉尼亚暨州立大学知识产权公司 |
使用脉冲电场选择性调节细胞的胞内影响
|
US10952891B1
(en)
|
2014-05-13 |
2021-03-23 |
Zeltiq Aesthetics, Inc. |
Treatment systems with adjustable gap applicators and methods for cooling tissue
|
US10568759B2
(en)
|
2014-08-19 |
2020-02-25 |
Zeltiq Aesthetics, Inc. |
Treatment systems, small volume applicators, and methods for treating submental tissue
|
US10935174B2
(en)
|
2014-08-19 |
2021-03-02 |
Zeltiq Aesthetics, Inc. |
Stress relief couplings for cryotherapy apparatuses
|
WO2016054003A1
(en)
|
2014-10-01 |
2016-04-07 |
The Trustees Of The University Of Pennsylvania |
Vaccines having an antigen and interleukin-21 as an adjuvant
|
US10694972B2
(en)
|
2014-12-15 |
2020-06-30 |
Virginia Tech Intellectual Properties, Inc. |
Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
|
US11116838B2
(en)
|
2015-01-29 |
2021-09-14 |
The Trustees Of The University Of Pennsylvania |
Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy
|
US10385115B2
(en)
|
2015-03-26 |
2019-08-20 |
Duke University |
Fibronectin type III domain-based fusion proteins
|
EA037478B1
(ru)
|
2015-08-04 |
2021-04-01 |
Дьюк Юниверсити |
Генетически кодируемые внутренне неупорядоченные полимеры-"невидимки" для доставки и способы их применения
|
US11154418B2
(en)
|
2015-10-19 |
2021-10-26 |
Zeltiq Aesthetics, Inc. |
Vascular treatment systems, cooling devices, and methods for cooling vascular structures
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
US20190015520A1
(en)
|
2015-12-21 |
2019-01-17 |
Duke University |
Polymer conjugates having reduced antigenicity and methods of using the same
|
KR20180099747A
(ko)
*
|
2015-12-28 |
2018-09-05 |
이노비오 파마수티컬즈, 인크. |
개선된 신호 발생기를 가진 전기천공 디바이스
|
CA3009414A1
(en)
|
2016-01-07 |
2017-07-13 |
Zeltiq Aesthetics, Inc. |
Temperature-dependent adhesion between applicator and skin during cooling of tissue
|
US10765552B2
(en)
|
2016-02-18 |
2020-09-08 |
Zeltiq Aesthetics, Inc. |
Cooling cup applicators with contoured heads and liner assemblies
|
WO2017173398A1
(en)
|
2016-04-01 |
2017-10-05 |
Duke University |
Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
|
US20190284263A1
(en)
|
2016-04-29 |
2019-09-19 |
Inovio Pharmaceuticals, Inc. |
In vivo use of chondroitinase and/or hyaluronidase to enhance delivery of an agent
|
US11382790B2
(en)
|
2016-05-10 |
2022-07-12 |
Zeltiq Aesthetics, Inc. |
Skin freezing systems for treating acne and skin conditions
|
US10555831B2
(en)
|
2016-05-10 |
2020-02-11 |
Zeltiq Aesthetics, Inc. |
Hydrogel substances and methods of cryotherapy
|
US10682297B2
(en)
|
2016-05-10 |
2020-06-16 |
Zeltiq Aesthetics, Inc. |
Liposomes, emulsions, and methods for cryotherapy
|
US11467156B2
(en)
|
2016-06-01 |
2022-10-11 |
Duke University |
Nonfouling biosensors
|
US10233419B2
(en)
|
2016-06-30 |
2019-03-19 |
Zymergen Inc. |
Apparatuses and methods for electroporation
|
US11135301B2
(en)
|
2016-09-14 |
2021-10-05 |
Duke University |
Triblock polypeptide-based nanoparticles for the delivery of hydrophilic drugs
|
EP3515928A4
(de)
|
2016-09-23 |
2020-04-01 |
Duke University |
Unstrukturierte nichtrepititive polypeptide mit lcst-verhalten
|
US10905492B2
(en)
|
2016-11-17 |
2021-02-02 |
Angiodynamics, Inc. |
Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
|
US10376495B2
(en)
|
2016-11-23 |
2019-08-13 |
University Of South Florida |
Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)
|
US11648200B2
(en)
|
2017-01-12 |
2023-05-16 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
US10813935B2
(en)
|
2017-02-23 |
2020-10-27 |
Transgenex Nanobiotech, Inc. |
Methods and compositions for treating drug resistance in cancer
|
WO2018156989A1
(en)
|
2017-02-24 |
2018-08-30 |
University Of South Florida |
The hsp90 activator aha1 drives production of pathological tau aggregates
|
US11076879B2
(en)
|
2017-04-26 |
2021-08-03 |
Zeltiq Aesthetics, Inc. |
Shallow surface cryotherapy applicators and related technology
|
US11554097B2
(en)
|
2017-05-15 |
2023-01-17 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
EP3658168A4
(de)
|
2017-06-30 |
2021-07-14 |
Duke University |
Ordnung und unordnung als designprinzip für auf stimuli ansprechende biopolymernetzwerke
|
KR102424850B1
(ko)
|
2017-06-30 |
2022-07-22 |
인스크립타 인코포레이티드 |
자동 세포 처리 방법, 모듈, 기기 및 시스템
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
US10738327B2
(en)
|
2017-08-28 |
2020-08-11 |
Inscripta, Inc. |
Electroporation cuvettes for automation
|
CN111372650A
(zh)
|
2017-09-30 |
2020-07-03 |
因思科瑞普特公司 |
流通式电穿孔仪器
|
US11607537B2
(en)
|
2017-12-05 |
2023-03-21 |
Virginia Tech Intellectual Properties, Inc. |
Method for treating neurological disorders, including tumors, with electroporation
|
US11311329B2
(en)
|
2018-03-13 |
2022-04-26 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
|
US11925405B2
(en)
|
2018-03-13 |
2024-03-12 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning system for immunotherapy enhancement via non-thermal ablation
|
CN112204131A
(zh)
|
2018-03-29 |
2021-01-08 |
因思科瑞普特公司 |
用于诱导和转化的细胞生长速率的自动化控制
|
WO2019200004A1
(en)
*
|
2018-04-13 |
2019-10-17 |
Inscripta, Inc. |
Automated cell processing instruments comprising reagent cartridges
|
US10526598B2
(en)
|
2018-04-24 |
2020-01-07 |
Inscripta, Inc. |
Methods for identifying T-cell receptor antigens
|
US10858761B2
(en)
|
2018-04-24 |
2020-12-08 |
Inscripta, Inc. |
Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
|
US10508273B2
(en)
|
2018-04-24 |
2019-12-17 |
Inscripta, Inc. |
Methods for identifying selective binding pairs
|
CN114854720A
(zh)
|
2018-06-30 |
2022-08-05 |
因思科瑞普特公司 |
用于改进活细胞中编辑序列的检测的仪器、模块和方法
|
CA3107932A1
(en)
|
2018-07-31 |
2020-02-06 |
Zeltiq Aesthetics, Inc. |
Methods, devices, and systems for improving skin characteristics
|
WO2020028806A1
(en)
|
2018-08-02 |
2020-02-06 |
Duke University |
Dual agonist fusion proteins
|
US11142740B2
(en)
|
2018-08-14 |
2021-10-12 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
US10752874B2
(en)
|
2018-08-14 |
2020-08-25 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
US10532324B1
(en)
|
2018-08-14 |
2020-01-14 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
CA3108892A1
(en)
|
2018-08-30 |
2020-04-23 |
Inscripta, Inc. |
Improved detection of nuclease edited sequences in automated modules and instruments
|
DE102018128723A1
(de)
*
|
2018-11-15 |
2020-05-20 |
Endress+Hauser Conducta Gmbh+Co. Kg |
Küvette, vorzugsweise Durchflussküvette für ein optisches Messgerät und Verfahren zu dessen Betrieb
|
US10907125B2
(en)
|
2019-06-20 |
2021-02-02 |
Inscripta, Inc. |
Flow through electroporation modules and instrumentation
|
CN114008070A
(zh)
|
2019-06-21 |
2022-02-01 |
因思科瑞普特公司 |
导致大肠杆菌赖氨酸产量增加的全基因组合理设计的突变
|
US10927385B2
(en)
|
2019-06-25 |
2021-02-23 |
Inscripta, Inc. |
Increased nucleic-acid guided cell editing in yeast
|
US11950835B2
(en)
|
2019-06-28 |
2024-04-09 |
Virginia Tech Intellectual Properties, Inc. |
Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
|
US20220228191A1
(en)
*
|
2019-07-02 |
2022-07-21 |
Horiba Advanced Techno, Co., Ltd. |
Biological sample analysis apparatus and biological sample analysis method
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
CN110511869B
(zh)
*
|
2019-08-08 |
2023-06-09 |
吉林大学 |
细胞培养方法及能产生可变脉冲电场的细胞培养装置
|
TW202128775A
(zh)
|
2019-10-16 |
2021-08-01 |
英商阿法克塔生命科學有限公司 |
PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
|
US10689669B1
(en)
|
2020-01-11 |
2020-06-23 |
Inscripta, Inc. |
Automated multi-module cell processing methods, instruments, and systems
|
US11225674B2
(en)
|
2020-01-27 |
2022-01-18 |
Inscripta, Inc. |
Electroporation modules and instrumentation
|
KR20220157969A
(ko)
|
2020-02-25 |
2022-11-29 |
이노비오 파마수티컬즈, 인크. |
코로나바이러스 백신 및 사용 방법
|
US20210332388A1
(en)
|
2020-04-24 |
2021-10-28 |
Inscripta, Inc. |
Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells
|
CN115803051A
(zh)
|
2020-05-14 |
2023-03-14 |
艾诺奥医药品有限公司 |
用于复发性呼吸道乳头状瘤病的疫苗及其使用方法
|
US11787841B2
(en)
|
2020-05-19 |
2023-10-17 |
Inscripta, Inc. |
Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
CN116133668A
(zh)
|
2020-06-12 |
2023-05-16 |
罗切斯特大学 |
ACE-tRNA的编码和表达
|
US12076071B2
(en)
|
2020-08-14 |
2024-09-03 |
Kardium Inc. |
Systems and methods for treating tissue with pulsed field ablation
|
EP4001396A1
(de)
*
|
2020-11-17 |
2022-05-25 |
Bühler AG |
Vorrichtung zur behandlung von zellen in einem bypass
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
EP4412711A1
(de)
|
2021-10-07 |
2024-08-14 |
Avacta Life Sciences Limited |
Serumhalbwertszeiterweiterte pd-l1-bindende polypeptide
|
EP4413038A1
(de)
|
2021-10-07 |
2024-08-14 |
Avacta Life Sciences Limited |
Pd-l1-bindende affimere
|
WO2023150753A1
(en)
|
2022-02-07 |
2023-08-10 |
University Of Rochester |
Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
|
WO2024102187A1
(en)
|
2022-11-07 |
2024-05-16 |
Pinetree Therapeutics, Inc. |
Combination therapy comprising bispecific antibodies comprising an nrp1 binding domain
|
WO2024129459A1
(en)
|
2022-12-16 |
2024-06-20 |
University Of Rochester |
Repairmen! of barrier dysfunction in esophagus
|